Churg-Strauss syndrome classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (19 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} {{APM}}; {{AE}} {{CK}} | {{CMG}} {{APM}}; {{AE}} {{CK}} | ||
==Overview== | ==Overview== | ||
Revised international chapel hill consensus conference 2012 on nomenclature of vasculitides, defines [[eosinophilic granulomatosis with polyangiitis]] (formerly known as Churg - Strauss syndrome) as an [[eosinophilic]], [[inflammation|granulomatous inflammatory disease]] affecting most commonly the [[Respiratory tract|conducting pulmonary airways]], and leading to a [[necrosis]] of the small and/or medium sized vessels. [[Eosinophilic granulomatosis with polyangiitis]] is often synonymous with adult-onset [[asthma]]. According to revised CHCC 2012, [[eosinophilic granulomatosis with polyangiitis]] is considered as a variant of the [[Anti-neutrophil cytoplasmic antibody|ANCA]] - associated vasculitides. | |||
[ | |||
[ | |||
According to | |||
==Classification== | ==Classification== | ||
*According to the | *According to the revised international chapel hill consensus conference 2012, [[eosinophilic granulomatosis with polyangiitis]] is described as an [[eosinophilic]], [[Granuloma|granulomatous]] [[inflammation|inflammatory disease]] affecting most commonly the [[Respiratory system|conducting pulmonary airways]], and leading to a [[necrosis]] of the small and/or medium sized [[Blood vessel|vessels]]. [[Eosinophilic granulomatosis with polyangiitis]] is often present with adult-onset [[asthma]].<ref name="pmid23045170">{{cite journal |vauthors=Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA |title=2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides |journal=Arthritis Rheum. |volume=65 |issue=1 |pages=1–11 |date=January 2013 |pmid=23045170 |doi=10.1002/art.37715 |url=}}</ref> | ||
*The name Churg–Strauss syndrome, has been replaced by the 2012 revised international chapel hill consensus conference, by focusing on the [[histopathology]] of the disease. [[Eosinophilic granulomatosis with polyangiitis]] can be considered a variant of the [[Anti-neutrophil cytoplasmic antibody|ANCA]] associated [[vasculitis]] of the small [[Blood vessel|vessels]].<ref name="pmid24530234">{{cite journal |vauthors=Mouthon L, Dunogue B, Guillevin L |title=Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome) |journal=J. Autoimmun. |volume=48-49 |issue= |pages=99–103 |date=2014 |pmid=24530234 |doi=10.1016/j.jaut.2014.01.018 |url=}}</ref> | |||
*The | *The revised CHCC 2012 nomenclature of vasculitides has stated that [[Anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibodies]] ([[Anti-neutrophil cytoplasmic antibody|ANCA]]) are found in [[eosinophilic granulomatosis with polyangiitis]], particularly in patients with [[glomerulonephritis]]. This evidence may support to describe subsets of of [[eosinophilic granulomatosis with polyangiitis]], wheather the presence or the absence of [[Anti-neutrophil cytoplasmic antibody|ANCA]]. | ||
*The | *The chapel hill consensus conference, however, does not propose any diagnostic or [[classification]] criteria. | ||
*Therefore, the diagnostic criteria proposed by the | *Therefore, the diagnostic criteria proposed by the american college of rheumatology (ACR) in 1990 on [[eosinophilic granulomatosis with polyangiitis]] is still being used to distinguish the disease. The presence of 4 out of the 6 diagnostic criteria has a reported 85% [[Sensitivity (tests)|sensitivity]] and 99.7% [[Specificity (tests)|specificity]] for the diagnosis of [[eosinophilic granulomatosis with polyangiitis]].<ref name="pmid2202307">{{cite journal| author=Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP et al.| title=The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). | journal=Arthritis Rheum | year= 1990 | volume= 33 | issue= 8 | pages= 1094-100 | pmid=2202307 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2202307 }}</ref><ref name="pmid25404930">{{cite journal| author=Gioffredi A, Maritati F, Oliva E, Buzio C| title=Eosinophilic granulomatosis with polyangiitis: an overview. | journal=Front Immunol | year= 2014 | volume= 5 | issue= | pages= 549 | pmid=25404930 | doi=10.3389/fimmu.2014.00549 | pmc=4217511 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25404930 }} </ref> | ||
{| class="wikitable" | {| class="wikitable" | ||
!American College of Rheumatology (ACR) Classification of Eosinophilic granulomatosis with polyangiitis | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |American College of Rheumatology (ACR) Classification of Eosinophilic granulomatosis with polyangiitis | ||
|- | |- | ||
|Asthma | |Asthma | ||
|- | |- | ||
|Eosinophilia > 10% | |Eosinophilia (>10% of total WBC) | ||
|- | |- | ||
|Neuropathy (mononeuropathy or polyneuropathy) | |Neuropathy (mononeuropathy or polyneuropathy) | ||
| Line 52: | Line 26: | ||
|Biopsy that shows extravascular eosinophil infiltration | |Biopsy that shows extravascular eosinophil infiltration | ||
|} | |} | ||
==References== | |||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Disease]] | ||
[[Category:Pulmonology]] | |||
[[Category:Autoimmune diseases]] | |||
[[Category:Rheumatology]] | |||
Latest revision as of 17:41, 12 April 2018
|
Churg-Strauss syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Churg-Strauss syndrome classification On the Web |
|
American Roentgen Ray Society Images of Churg-Strauss syndrome classification |
|
Risk calculators and risk factors for Churg-Strauss syndrome classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [3]
Overview
Revised international chapel hill consensus conference 2012 on nomenclature of vasculitides, defines eosinophilic granulomatosis with polyangiitis (formerly known as Churg - Strauss syndrome) as an eosinophilic, granulomatous inflammatory disease affecting most commonly the conducting pulmonary airways, and leading to a necrosis of the small and/or medium sized vessels. Eosinophilic granulomatosis with polyangiitis is often synonymous with adult-onset asthma. According to revised CHCC 2012, eosinophilic granulomatosis with polyangiitis is considered as a variant of the ANCA - associated vasculitides.
Classification
- According to the revised international chapel hill consensus conference 2012, eosinophilic granulomatosis with polyangiitis is described as an eosinophilic, granulomatous inflammatory disease affecting most commonly the conducting pulmonary airways, and leading to a necrosis of the small and/or medium sized vessels. Eosinophilic granulomatosis with polyangiitis is often present with adult-onset asthma.[1]
- The name Churg–Strauss syndrome, has been replaced by the 2012 revised international chapel hill consensus conference, by focusing on the histopathology of the disease. Eosinophilic granulomatosis with polyangiitis can be considered a variant of the ANCA associated vasculitis of the small vessels.[2]
- The revised CHCC 2012 nomenclature of vasculitides has stated that anti-neutrophil cytoplasmic antibodies (ANCA) are found in eosinophilic granulomatosis with polyangiitis, particularly in patients with glomerulonephritis. This evidence may support to describe subsets of of eosinophilic granulomatosis with polyangiitis, wheather the presence or the absence of ANCA.
- The chapel hill consensus conference, however, does not propose any diagnostic or classification criteria.
- Therefore, the diagnostic criteria proposed by the american college of rheumatology (ACR) in 1990 on eosinophilic granulomatosis with polyangiitis is still being used to distinguish the disease. The presence of 4 out of the 6 diagnostic criteria has a reported 85% sensitivity and 99.7% specificity for the diagnosis of eosinophilic granulomatosis with polyangiitis.[3][4]
| American College of Rheumatology (ACR) Classification of Eosinophilic granulomatosis with polyangiitis |
|---|
| Asthma |
| Eosinophilia (>10% of total WBC) |
| Neuropathy (mononeuropathy or polyneuropathy) |
| Pulmonary infiltrate |
| Paranasal sinus abnormality |
| Biopsy that shows extravascular eosinophil infiltration |
References
- ↑ Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (January 2013). "2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides". Arthritis Rheum. 65 (1): 1–11. doi:10.1002/art.37715. PMID 23045170.
- ↑ Mouthon L, Dunogue B, Guillevin L (2014). "Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome)". J. Autoimmun. 48-49: 99–103. doi:10.1016/j.jaut.2014.01.018. PMID 24530234.
- ↑ Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP; et al. (1990). "The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)". Arthritis Rheum. 33 (8): 1094–100. PMID 2202307.
- ↑ Gioffredi A, Maritati F, Oliva E, Buzio C (2014). "Eosinophilic granulomatosis with polyangiitis: an overview". Front Immunol. 5: 549. doi:10.3389/fimmu.2014.00549. PMC 4217511. PMID 25404930.